322 related articles for article (PubMed ID: 30258436)
1. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression.
Sebastián VP; Salazar GA; Coronado-Arrázola I; Schultz BM; Vallejos OP; Berkowitz L; Álvarez-Lobos MM; Riedel CA; Kalergis AM; Bueno SM
Front Immunol; 2018; 9():1956. PubMed ID: 30258436
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota.
Onyiah JC; Sheikh SZ; Maharshak N; Otterbein LE; Plevy SE
Gut Microbes; 2014; 5(2):220-4. PubMed ID: 24637794
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
4. Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease.
Gombošová L; Lazúrová I; Zakuciová M; Curová K; Kmeťová M; Petrášová D; Siegfried L
Folia Microbiol (Praha); 2011 Sep; 56(5):367-72. PubMed ID: 21877213
[TBL] [Abstract][Full Text] [Related]
5. Promises and paradoxes of regulatory T cells in inflammatory bowel disease.
Lord JD
World J Gastroenterol; 2015 Oct; 21(40):11236-45. PubMed ID: 26523099
[TBL] [Abstract][Full Text] [Related]
6. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
7. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.
Ryan FJ; Ahern AM; Fitzgerald RS; Laserna-Mendieta EJ; Power EM; Clooney AG; O'Donoghue KW; McMurdie PJ; Iwai S; Crits-Christoph A; Sheehan D; Moran C; Flemer B; Zomer AL; Fanning A; O'Callaghan J; Walton J; Temko A; Stack W; Jackson L; Joyce SA; Melgar S; DeSantis TZ; Bell JT; Shanahan F; Claesson MJ
Nat Commun; 2020 Mar; 11(1):1512. PubMed ID: 32251296
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
Bates J; Diehl L
J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Palm NW; de Zoete MR; Cullen TW; Barry NA; Stefanowski J; Hao L; Degnan PH; Hu J; Peter I; Zhang W; Ruggiero E; Cho JH; Goodman AL; Flavell RA
Cell; 2014 Aug; 158(5):1000-1010. PubMed ID: 25171403
[TBL] [Abstract][Full Text] [Related]
10. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
Nanini HF; Bernardazzi C; Castro F; de Souza HSP
World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
[TBL] [Abstract][Full Text] [Related]
11. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders.
Loktionov A
World J Gastroenterol; 2019 Jul; 25(27):3503-3526. PubMed ID: 31367153
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease.
Yao S; Zhao Z; Wang W; Liu X
J Immunol Res; 2021; 2021():8030297. PubMed ID: 34337079
[TBL] [Abstract][Full Text] [Related]
13. Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
[TBL] [Abstract][Full Text] [Related]
14. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
15. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.
Maronek M; Link R; Ambro L; Gardlik R
Cells; 2020 Apr; 9(4):. PubMed ID: 32325706
[TBL] [Abstract][Full Text] [Related]
16. Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis.
Katsurada T; Kobayashi W; Tomaru U; Baba T; Furukawa S; Ishizu A; Takeda K; Sakamoto N; Asaka M; Takeda H; Kasahara M
PLoS One; 2012; 7(9):e44113. PubMed ID: 22970169
[TBL] [Abstract][Full Text] [Related]
17. The microbiome and inflammatory bowel disease.
Glassner KL; Abraham BP; Quigley EMM
J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota and ulcerative colitis.
Ohkusa T; Koido S
J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
[TBL] [Abstract][Full Text] [Related]
19. IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota.
Cococcioni L; Panelli S; Varotto-Boccazzi I; Carlo DD; Pistone D; Leccese G; Zuccotti GV; Comandatore F
Dig Liver Dis; 2021 Jan; 53(1):17-25. PubMed ID: 33189590
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
